Kicking off series two of the High Potential Start-ups Podcast, Jack O’Meara, co-founder and CEO of Ochre Bio, and host Nick Ross, Co-Founder of Cavenagh Health discuss the future of liver therapeutics and innovation in the biotech industry.

Ochre Bio is using AI to develop novel RNA liver therapeutics for liver disease, a chronic disease that claims more lives than all cancers combined.

They explore the potential of AI in target discovery and drug development, and how it can revolutionise the productivity of the industry in the coming years.

Available To Listen On

Nick Ross

Author Nick Ross

More posts by Nick Ross

Leave a Reply